1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Adenocarcinoma, Renal: new trials by email Literature Review of Adenocarcinoma, Renal trials Research Report on Adenocarcinoma, Renal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension - Renal Cell Carcinoma, Kidney Cancer | Phase 1 | Withdrawn | NanOlogy, LLC | 2020-04-01 | 2020-08-04 |
Carcinoma, Renal Cell (1) · Kidney Neoplasms (1)
Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Docetaxel (1) · Powders (1) · Suspensions (1)
NanOlogy, LLC (1)